The programme features leading speakers from the investment banking and money management & VC community.

Jan Wald, Analyst, AG Edwards & Sons
Dr Maggie Flanagan, Global Alliance Director, Enabling Science, Technology and Information, AstraZeneca Pharmaceuticals
Dr Klaus Wilgenbus, Head of Corporate Division, Licensing, Boehringer Ingelheim
Marc Goldberg, Managing Director, BioVentures Investors
G. Steven Burrill, CEO, Burrill & Company
William C Mills III, Managing Member, EGS Healthcare Capital Partners
Robert Schmid, Director, Alliance Management, Eli Lilly & Company
Stan Yakatan, Chairman, Katan Associates
Lothar Krinke, Senior Director BioSciences Technology Development, Medtronic
Dr Robert Gould, Vice President, External Scientific Affairs Worldwide, Merck & Co
Dr Ansbert Gadicke, Founding General Partner & Chairman, MPM Capital
Michael Lytton, General Partner, Oxford Bioscience Partners
Kathleen Williams, Co-Chair of Life Sciences, Palmer & Dodge
Christoph Westphal, General Partner, Polaris Venture Partners
Chuck Hadley, Managing Director, Rock Hill Ventures
Stelios Papadopoulos, Vice Chairman, SG Cowen Securities Corporation
James M Garvey, CEO & Managing Partner, SV Life Sciences
Dr Heinrich Henkel, CEO, SWX Swiss Exchange
Jonathan Leff, Managing Director, Warburg Pincus
Ben Bronstein, Zero Stage Capital